Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · July 04, 2018

Favorable Outcomes Associated With Apixaban Use in End-Stage Kidney Disease Patients With Atrial Fibrillation

Circulation

 

Additional Info

Circulation
Outcomes Associated With Apixaban Use in End-Stage Kidney Disease Patients With Atrial Fibrillation in the United States
Circulation 2018 Jun 28;[EPub Ahead of Print], KC Siontis, X Zhang, A Eckard, N Bhave, DE Schaubel, K He, A Tilea, AG Stack, R Balkrishnan, X Yao, PA Noseworthy, ND Shah, R Saran, BK Nallamothu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading